Kenneth S. GRAHAM

Person

Pleasant Valley, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods for treating angiogenic eye disorders with high doses of VE...
- Patent number 12,168,036
- Issue date Dec 17, 2024
- REGENERON PHARMACEUTICALS, INC.
- Kenneth S. Graham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized formulations containing anti-interleukin-6 receptor (IL-...
- Patent number 12,077,593
- Issue date Sep 3, 2024
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Devices and methods for overfilling drug containers
- Patent number 11,918,785
- Issue date Mar 5, 2024
- Regeneron Pharmaceuticals Inc.
- Daniel B. Dix
- B65 - CONVEYING PACKING STORING HANDLING THIN OR FILAMENTARY MATERIAL
Information Patent Grant
VEGF antagonist formulations suitable for intravitreal administration
- Patent number 11,732,024
- Issue date Aug 22, 2023
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Devices and methods for overfilling drug containers
- Patent number 11,577,025
- Issue date Feb 14, 2023
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- B65 - CONVEYING PACKING STORING HANDLING THIN OR FILAMENTARY MATERIAL
Information Patent Grant
High concentration VEGF receptor fusion protein containing formulat...
- Patent number 11,103,552
- Issue date Aug 31, 2021
- REGENERON PHARMACEUTICALS, INC.
- Kenneth S. Graham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized formulations containing anti-interleukin-6 receptor (IL-...
- Patent number 11,098,127
- Issue date Aug 24, 2021
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGF antagonist formulations suitable for intravitreal administration
- Patent number 11,084,865
- Issue date Aug 10, 2021
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and formulations for treating vascular eye diseases using a...
- Patent number 11,071,780
- Issue date Jul 27, 2021
- REGENERON PHARMACEUTICALS, INC.
- Robert L. Vitti
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
VEGF antagonist formulations suitable for intravitreal administration
- Patent number 11,066,458
- Issue date Jul 20, 2021
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
VEGF antagonist formulations suitable for intravitreal administration
- Patent number 10,464,992
- Issue date Nov 5, 2019
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
VEGF antagonist formulations suitable for intravitreal administration
- Patent number 10,400,025
- Issue date Sep 3, 2019
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stabilized formulations containing anti-interleukin-6 receptor (IL-...
- Patent number 10,072,086
- Issue date Sep 11, 2018
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
VEGF antagonist formulations suitable for intravitreal administration
- Patent number 9,914,763
- Issue date Mar 13, 2018
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGF antagonist formulations suitable for intravitreal administration
- Patent number 9,580,489
- Issue date Feb 28, 2017
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGF antagonist formulations for intravitreal administration
- Patent number 9,340,594
- Issue date May 17, 2016
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized formulations containing anti-interleukin-6 receptor (IL-...
- Patent number 9,173,880
- Issue date Nov 3, 2015
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGF antagonist formulations for intravitreal administration
- Patent number 8,802,107
- Issue date Aug 12, 2014
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGF antagonist formulations for intravitreal administration
- Patent number 8,481,046
- Issue date Jul 9, 2013
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGF antagonist formulations for intravitreal administration
- Patent number 8,092,803
- Issue date Jan 10, 2012
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Lyophilized VEGF antagonist formulations for intravitreal administr...
- Patent number 7,807,164
- Issue date Oct 5, 2010
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGF antagonist formulations suitable for intravitreal administration
- Patent number 7,608,261
- Issue date Oct 27, 2009
- Regeneron Pharmacuticals, Inc.
- Eric Furfine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Stabilized Formulations Containing Anti-BCMA x Anti-CD3 Bispecific...
- Publication number 20250041411
- Publication date Feb 6, 2025
- Regeneron Pharmaceuticals, Inc.
- Kenneth S. Graham
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
- Publication number 20250042972
- Publication date Feb 6, 2025
- Regeneron Pharmaceuticals, Inc.
- Eric FURFINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYSTEM SUITABILITY PARAMETERS AND COLUMN AGING
- Publication number 20240280551
- Publication date Aug 22, 2024
- Regeneron Pharmaceuticals, Inc.
- Shao-Chung Wang
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF MODELING LIQUID PROTEIN COMPOSITION STABILITY
- Publication number 20240245779
- Publication date Jul 25, 2024
- Regeneron Pharmaceuticals, Inc.
- Douglas E. KAMEN
- G01 - MEASURING TESTING
Information Patent Application
DEVICES AND METHODS FOR OVERFILLING DRUG CONTAINERS
- Publication number 20240207516
- Publication date Jun 27, 2024
- REGENERON PHARMACEUTICALS INC.
- Daniel B. DIX
- B65 - CONVEYING PACKING STORING HANDLING THIN OR FILAMENTARY MATERIAL
Information Patent Application
High Concentration VEGF Receptor Fusion Protein Containing Formulat...
- Publication number 20240058418
- Publication date Feb 22, 2024
- Regeneron Pharmaceuticals, Inc.
- Kenneth S. Graham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
- Publication number 20230374108
- Publication date Nov 23, 2023
- Regeneron Pharmaceuticals, Inc.
- Eric FURFINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DEVICES AND METHODS FOR OVERFILLING DRUG CONTAINERS
- Publication number 20230158237
- Publication date May 25, 2023
- REGENERON PHARMACEUTICALS INC.
- Daniel B. DIX
- B65 - CONVEYING PACKING STORING HANDLING THIN OR FILAMENTARY MATERIAL
Information Patent Application
Stabilized Formulations Containing Anti-MUC16 x Anti-CD3 Bispecific...
- Publication number 20220332849
- Publication date Oct 20, 2022
- Regeneron Pharmaceuticals, Inc.
- Douglas Kamen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods for Predicting and Modulating Glycation of a Protein
- Publication number 20220326250
- Publication date Oct 13, 2022
- Regeneron Pharmaceuticals, Inc.
- Xiaobin Xu
- G01 - MEASURING TESTING
Information Patent Application
ACTIVIN A ANTIBODY FORMULATIONS AND METHODS OF USE THEREOF
- Publication number 20210393779
- Publication date Dec 23, 2021
- Regeneron Pharmaceuticals, Inc.
- Douglas Kamen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
High Concentration VEGF Receptor Fusion Protein Containing Formulat...
- Publication number 20210353714
- Publication date Nov 18, 2021
- Regeneron Pharmaceuticals, Inc.
- Kenneth S. Graham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
- Publication number 20210340220
- Publication date Nov 4, 2021
- Regeneron Pharmaceuticals, Inc.
- Eric FURFINE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-...
- Publication number 20210230283
- Publication date Jul 29, 2021
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DEVICES AND METHODS FOR OVERFILLING DRUG CONTAINERS
- Publication number 20200155760
- Publication date May 21, 2020
- REGENERON PHARMACEUTICALS INC.
- Daniel B. DIX
- B65 - CONVEYING PACKING STORING HANDLING THIN OR FILAMENTARY MATERIAL
Information Patent Application
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
- Publication number 20200131246
- Publication date Apr 30, 2020
- Regeneron Pharmaceuticals, Inc.
- Eric FURFINE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
- Publication number 20200017572
- Publication date Jan 16, 2020
- Regeneron Pharmaceuticals, Inc.
- Eric FURFINE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HIGH CONCENTRATION VEGF RECEPTOR FUSION PROTEIN CONTAINING FORMULAT...
- Publication number 20190343918
- Publication date Nov 14, 2019
- Regeneron Pharmaceuticals, Inc.
- Kenneth S. Graham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND FORMULATIONS FOR TREATING VASCULAR EYE DISEASES
- Publication number 20190117767
- Publication date Apr 25, 2019
- Regeneron Pharmaceuticals, Inc.
- Robert L. VITTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
- Publication number 20190031735
- Publication date Jan 31, 2019
- Regeneron Pharmaceuticals, Inc.
- Eric FURFINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-...
- Publication number 20190002574
- Publication date Jan 3, 2019
- Regeneron Pharmaceuticals, Inc.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
- Publication number 20180155408
- Publication date Jun 7, 2018
- Regeneron Pharmaceuticals, Inc.
- Eric FURFINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND FORMULATIONS FOR TREATING VASCULAR EYE DISEASES
- Publication number 20170080086
- Publication date Mar 23, 2017
- Regeneron Pharmaceuticals, Inc.
- Robert L. VITTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
- Publication number 20160244505
- Publication date Aug 25, 2016
- Regeneron Pharmaceuticals, Inc.
- Eric FURFINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
- Publication number 20160213608
- Publication date Jul 28, 2016
- Regeneron Pharmaceuticals, Inc.
- Eric FURFINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND FORMULATIONS FOR TREATING VASCULAR EYE DISEASES
- Publication number 20160144025
- Publication date May 26, 2016
- Regeneron Pharmaceuticals, Inc.
- Robert L. VITTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-...
- Publication number 20160002341
- Publication date Jan 7, 2016
- Regeneron Pharmaceuticals, Inc.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF Antagonist Formulations for Intravitreal Administration
- Publication number 20140323983
- Publication date Oct 30, 2014
- Eric FURFINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF Antagonist Formulations for Intravitreal Administration
- Publication number 20130274189
- Publication date Oct 17, 2013
- Eric FURFINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF Antagonist Formulations for Intravitreal Administration
- Publication number 20120087929
- Publication date Apr 12, 2012
- Regeneron Pharmaceuticals, Inc.
- Eric FURFINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Kenneth S. GRAHAM

Person

Patents Grantslast 30 patents

Methods for treating angiogenic eye disorders with high doses of VE...

Stabilized formulations containing anti-interleukin-6 receptor (IL-...

Devices and methods for overfilling drug containers

VEGF antagonist formulations suitable for intravitreal administration

Devices and methods for overfilling drug containers

High concentration VEGF receptor fusion protein containing formulat...

Stabilized formulations containing anti-interleukin-6 receptor (IL-...

VEGF antagonist formulations suitable for intravitreal administration

Methods and formulations for treating vascular eye diseases using a...

VEGF antagonist formulations suitable for intravitreal administration

VEGF antagonist formulations suitable for intravitreal administration

VEGF antagonist formulations suitable for intravitreal administration

Stabilized formulations containing anti-interleukin-6 receptor (IL-...

VEGF antagonist formulations suitable for intravitreal administration

VEGF antagonist formulations suitable for intravitreal administration

VEGF antagonist formulations for intravitreal administration

Stabilized formulations containing anti-interleukin-6 receptor (IL-...

VEGF antagonist formulations for intravitreal administration

VEGF antagonist formulations for intravitreal administration

VEGF antagonist formulations for intravitreal administration

Lyophilized VEGF antagonist formulations for intravitreal administr...

VEGF antagonist formulations suitable for intravitreal administration

Patents Applicationslast 30 patents

Stabilized Formulations Containing Anti-BCMA x Anti-CD3 Bispecific...

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

SYSTEM SUITABILITY PARAMETERS AND COLUMN AGING

METHODS OF MODELING LIQUID PROTEIN COMPOSITION STABILITY

DEVICES AND METHODS FOR OVERFILLING DRUG CONTAINERS

High Concentration VEGF Receptor Fusion Protein Containing Formulat...

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

DEVICES AND METHODS FOR OVERFILLING DRUG CONTAINERS

Stabilized Formulations Containing Anti-MUC16 x Anti-CD3 Bispecific...

Methods for Predicting and Modulating Glycation of a Protein

ACTIVIN A ANTIBODY FORMULATIONS AND METHODS OF USE THEREOF

High Concentration VEGF Receptor Fusion Protein Containing Formulat...

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-...

DEVICES AND METHODS FOR OVERFILLING DRUG CONTAINERS

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

HIGH CONCENTRATION VEGF RECEPTOR FUSION PROTEIN CONTAINING FORMULAT...

METHODS AND FORMULATIONS FOR TREATING VASCULAR EYE DISEASES

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-...

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

METHODS AND FORMULATIONS FOR TREATING VASCULAR EYE DISEASES

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

METHODS AND FORMULATIONS FOR TREATING VASCULAR EYE DISEASES

Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-...

VEGF Antagonist Formulations for Intravitreal Administration

VEGF Antagonist Formulations for Intravitreal Administration

VEGF Antagonist Formulations for Intravitreal Administration